Home › Endometrial Cancer › North Carolina › Raleigh

Endometrial Cancer clinical trials in Raleigh, NC

5 studies for Endometrial Cancer are looking for participants at sites in and around Raleigh (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

RecruitingPhase 2

Duke Women's Cancer Care Raleigh, Raleigh

All ages · All sexes · Updated Oct 2, 2026 · NCT05564377

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

RecruitingPhase 3

Duke Women's Cancer Care Raleigh, Raleigh

Ages 18 and older · Women · Updated Oct 2, 2026 · NCT07198074

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

RecruitingPhase 2

Duke Women's Cancer Care Raleigh, Raleigh

Ages 18 and older · Women · Updated Sep 28, 2026 · NCT05112601

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

RecruitingPhase 2

Duke Womens Cancer Care Raleigh, Raleigh

Ages 18 and older · Women · Updated Sep 24, 2026 · NCT05640999

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

RecruitingPhase 1

Investigative Site #131, Raleigh

Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT06974110

Endometrial Cancer trials in other cities

Other studies in Raleigh

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.